CS logo
small CS logo
Gwinnett Medical Center

Lawrenceville, Georgia, United States
Hospital in Lawrenceville, Georgia
1000 Medical Center Blvd, Lawrenceville, GA 30046

About Gwinnett Medical Center


Northside Hospital Gwinnett is a part of the Northside Hospital network of healthcare facilities and providers in Gwinnett County, Georgia, United States, comprising the following licensed facilities: Northside Hospital Gwinnett - a hospital with 353 acute care beds in Lawrenceville, GA.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
SWOG Cancer Research Network
42
National Cancer Institute (NCI)
35
Alliance for Clinical Trials in Oncology
13
ECOG-ACRIN Cancer Research Group
8
NSABP Foundation Inc
5
Boston Scientific Corporation
3
Bristol-Myers Squibb
3
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
3
Abbott Medical Devices
2
Alliance Foundation Trials, LLC.
2
Banyan Biomarkers, Inc
2
Total Rows: 23

Clinical Trials at Gwinnett Medical Center


During the past decade, Gwinnett Medical Center conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 59 clinical trials were completed, i.e. on average, 178.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 18 clinical trials were completed. i.e. 257.1% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years556666009944221188121210104477445555Started TrialsCompleted Trails20152016201720182019202020212022051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
S0001 RT and Carmustine With or Without O6BG in Patients With New Glioblastoma Multiforme or Gliosarcoma
2001-09-01
2012-11-01
Completed
183
Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer
2001-09-01
2012-11-01
Completed
633
S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
2002-06-01
2015-10-01
Completed
147
S0124: Cisplatin Combined With Irinotecan or Etoposide For Extensive-Stage Small Cell Lung Cancer
2002-11-01
2009-12-01
Completed
671

Rows per page:

1–100 of 130

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Gwinnett Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 42 trials, followed by "National Cancer Institute (NCI)" with 35 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 8 trials sponsored and "NSABP Foundation Inc" with 8 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 23 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gwinnett Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 74 trials as a collaborator, "Cancer and Leukemia Group B" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 10 trials as a collaborator, "North Central Cancer Treatment Group" with 8 trials as a collaborator and "SWOG Cancer Research Network" with 8 trials as a collaborator. Other collaborators include 36 different institutions and companies that were collaborators in the rest 31 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSWOG Cancer ResearchNetwork: 42SWOG Cancer ResearchNetwork: 42National CancerInstitute (NCI): 35National CancerInstitute (NCI): 35Alliance for ClinicalTrials in Oncology: 13Alliance for ClinicalTrials in Oncology: 13ECOG-ACRIN CancerResearch Group: 8ECOG-ACRIN CancerResearch Group: 8NSABP Foundation Inc: 5NSABP Foundation Inc: 5Boston Scientific Corporation: 3Boston Scientific Corporation: 3Bristol-Myers Squibb: 3Bristol-Myers Squibb: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3JANSSEN AlzheimerImmunotherapyResearch &Development, LLC: 3Abbott Medical Devices: 2Abbott Medical Devices: 2Alliance FoundationTrials, LLC.: 2Alliance FoundationTrials, LLC.: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 74National CancerInstitute (NCI): 74Cancer and LeukemiaGroup B: 10Cancer and LeukemiaGroup B: 10NCIC Clinical Trials Group: 10NCIC Clinical Trials Group: 10North Central CancerTreatment Group: 8North Central CancerTreatment Group: 8SWOG Cancer ResearchNetwork: 8SWOG Cancer ResearchNetwork: 8Eastern CooperativeOncology Group: 5Eastern CooperativeOncology Group: 5NRG Oncology: 5NRG Oncology: 5Pfizer: 3Pfizer: 3American College ofSurgeons: 2American College ofSurgeons: 2Canadian Cancer Trials Group: 2Canadian Cancer Trials Group: 2

Clinical Trials Conditions at Gwinnett Medical Center


According to Clinical.Site data, the most researched conditions in "Gwinnett Medical Center" are "Breast Cancer" (14 trials), "Lung Cancer" (9 trials), "Lymphoma" (8 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IVA Lung Cancer AJCC v8" (7 trials). Many other conditions were trialed in "Gwinnett Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Gwinnett Medical Center


Most popular intervention types in "Gwinnett Medical Center" are "Drug" (95 trials), "Other" (69 trials), "Biological" (51 trials), "Procedure" (18 trials) and "Radiation" (12 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (31 trials), "Quality-of-Life Assessment" (20 trials), "Paclitaxel" (14 trials), "Questionnaire Administration" (11 trials) and "Bevacizumab" (10 trials). Other intervention names were less common.

Clinical Trials Genders at Gwinnett Medical Center


The vast majority of trials in "Gwinnett Medical Center" are 106 trials for "All" genders, 21 trials for "Female" genders and 3 trials for "Male" genders.

Clinical Trials Status at Gwinnett Medical Center


Currently, there are NaN active trials in "Gwinnett Medical Center". undefined are not yet recruiting, 13 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 67 completed trials in Gwinnett Medical Center, undefined suspended trials, and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Gwinnett Medical Center, 1 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 74Phase 3: 74Phase 2: 34Phase 2: 34Not Applicable: 4Not Applicable: 4Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 67Completed: 67Active, not recruiting: 42Active, not recruiting: 42Recruiting: 13Recruiting: 13Terminated: 8Terminated: 8